Daniel N Cagney

Daniel N Cagney

Harvard University

H-index: 23

North America-United States

About Daniel N Cagney

Daniel N Cagney, With an exceptional h-index of 23 and a recent h-index of 21 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Clinical Director of Radiation Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Stereotactic Magnetic Resonance–guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence

Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART)

Inaugural results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A phase II platform trial for newly diagnosed glioblastoma using Bayesian adaptive …

MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease

NIMG-52. CORRELATION OF BIDIMENSIONAL AND VOLUMETRIC TUMOR SIZING IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF …

Genomic Predictors of Leptomeningeal Disease Development among Patients with Brain Metastases

Daniel N Cagney Information

University

Position

Harvard Medical School / Dana-Farber Cancer Institute / Brigham and Women's Hospital

Citations(all)

3267

Citations(since 2020)

2944

Cited By

1166

hIndex(all)

23

hIndex(since 2020)

21

i10Index(all)

42

i10Index(since 2020)

38

Email

University Profile Page

Google Scholar

Daniel N Cagney Skills & Research Interests

Clinical Director of Radiation Oncology

Top articles of Daniel N Cagney

Stereotactic Magnetic Resonance–guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort

European Urology Oncology

2024/2/1

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence

Clinical and Translational Radiation Oncology

2024/1/1

Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART)

Radiotherapy and Oncology

2024/1/1

Inaugural results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A phase II platform trial for newly diagnosed glioblastoma using Bayesian adaptive …

Journal of Clinical Oncology

2023/12/20

MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease

World Journal of Urology

2023/12

NIMG-52. CORRELATION OF BIDIMENSIONAL AND VOLUMETRIC TUMOR SIZING IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Neuro-Oncology

2023/11/1

CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF …

Neuro-Oncology

2023/11/1

Genomic Predictors of Leptomeningeal Disease Development among Patients with Brain Metastases

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

A genomic score to predict local control among patients with brain metastases managed with radiation

Neuro-Oncology

2023/10/1

Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)

JNCI: Journal of the National Cancer Institute

2023/8/1

Evaluation of standard response assessment in neuro-oncology, modified response assessment in neuro-oncology, and immunotherapy response assessment in neuro-oncology in newly …

Journal of Clinical Oncology

2023/6/10

Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity

Neuro-oncology

2023/6/1

Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries

Neuro-oncology

2023/5/1

Patient specific distortion detection and mitigation in MR images used for stereotactic radiosurgery

Physics in Medicine & Biology

2022/3/11

Predictors of long-term survival among patients with brain metastases

Neuro-oncology

2022/3/1

Central Nervous System Malignancies

2022/2/1

Update on radiation therapy for central nervous system tumors

2022/2/1

Daniel N Cagney
Daniel N Cagney

H-Index: 14

Stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) for abdominopelvic oligometastases

International Journal of Radiation Oncology* Biology* Physics

2022/12/1

Elizabeth Huynh
Elizabeth Huynh

H-Index: 21

Daniel N Cagney
Daniel N Cagney

H-Index: 14

Leveraging Serial MRI Radiomics and Machine Learning to Predict Risk of Radiation Necrosis in Patients with Brain Metastases Managed with Stereotactic Radiation and Immunotherapy

International Journal of Radiation Oncology, Biology, Physics

2022/11/1

Safety and efficacy of stereotactic mri-guided adaptive radiation therapy for localized kidney cancer

International Journal of Radiation Oncology* Biology* Physics

2022/11/1

See List of Professors in Daniel N Cagney University(Harvard University)